Kia ora
Thank you for your requests for official information received on 27
October 2020 for:

"I understand that various medicinal cannabis products are currently
undergoing reviews to become approved medicines. This includes MediPharm
Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
entered in to supply agreements for.

Can you please supply a list of products that:
1. Have been considered for approval as approved medicines, with a final
outcome decided.
2. Were not considered for approval as approved medicines, as they did not
meet basic or qualifying criteria.
3. Are currently under consideration for approval as approved medicines."

The Ministry's reference number for your request is: H202007996.
As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 24 November 2020, being
20 working days after the day your request was received.  
If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]

--------------------------------------------------------------------------

From: B. Haddock <[FOI #14043 email]>
Sent: Tuesday, 27 October 2020 20:44
To: OIA Requests <[email address]>
Subject: Official Information request - Number and status of medicinal
cannabis product approvals
 
Dear Ministry of Health / Medicinal Cannabis Agency,

I understand that various medicinal cannabis products are currently
undergoing reviews to become approved medicines. This includes MediPharm
Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
entered in to supply agreements for.

Can you please supply a list of products that:
1. Have been considered for approval as approved medicines, with a final
outcome decided.
2. Were not considered for approval as approved medicines, as they did not
meet basic or qualifying criteria.
3. Are currently under consideration for approval as approved medicines.

For point #3 above, I would appreciate any information around expected
timelines for approval. Alternatively, a statement of whether you expect
additional cannabis products as approved medicines (beyond Sativex) to be
available on the market this year.

Thank you for your time
B Haddock

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #14043 email]

Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[1]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

show quoted sections

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://scanmail.trustwave.com/?c=15517&...
2. https://scanmail.trustwave.com/?c=15517&...

Kia ora B Haddock

Thank you for your request for official information, received on 27
October 2020 requesting:

“I understand that various medicinal cannabis products are currently
undergoing reviews to become approved medicines. This includes MediPharm
Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
entered in to supply agreements for.
Can you please supply a list of products that:
1. Have been considered for approval as approved medicines, with a final
outcome decided.
2. Were not considered for approval as approved medicines, as they did not
meet basic or qualifying criteria.
3. Are currently under consideration for approval as approved medicines.”

The Ministry of Health has decided to extend the period of time available
to respond to your request under section 15A of the Official Information
Act 1982 (the Act) as further consultation is required.

You can now expect a response to your request on, or before, 4 December
2020.

You have the right, under section 28 of the Act, to ask the Ombudsman to
review my decision to extend the time available to respond to your
request.

Ngâ mihi

 

Caitlin Finnegan-Ramanui
Advisor | OIA Services
Office of the Director-General
Ministry of Health
E: [1][email address]
L1 North, Yellow, 113 Molesworth St, Wellington

 

show quoted sections

References

Visible links
1. mailto:[email address]

Kia ora B Haddock

 

Please find attached the response to your request for official
information.

 

Nga mihi,

 

Caitlin Finnegan-Ramanui
Advisor | OIA Services
Office of the Director-General
Ministry of Health
E: [1][email address]
L1 North, Yellow, 113 Molesworth St, Wellington

 

show quoted sections

References

Visible links
1. mailto:[email address]